Lingotto Innovation's James Anderson and Morgan Samet favor companies with explosive growth potential and a focus on innovation.

MPWR's historical valuation multiples are high, but justified by its consistent growth and strong business model. The company's products offer real performance advantages, granting it pricing power in targeted markets. Investing in Monolithic Power Systems can be approached by building a long-term position or buying during rare valuation dips.

International Paper said on Friday it will close five packaging sites in Britain, cutting around 300 jobs, citing tough industry conditions.

Josh Young at Bison Interest says oil could return to $100 per barrel this year, even as OPEC+ considers another output hike in July.

XPeng's 2025 China sales surged to 72% of Tesla's, up from 17% last year, showcasing rapid market share gains. Strong Mona M03 model sales and growing exports signal XPeng's increasing global competitiveness. XPeng's tech edge, including high XNGP adoption and new ADAS insurance, boosts its valuation potential.

DIVERSIFIED ENERGY COMPANY PLC ("Diversified", or the "Company") DIVERSIFIED ENERGY COMPANY PLC (LSE:DEC, NYSE:DEC) announces that, in accordance with the terms of its share buyback programme announced on 20 March 2025, the Company has purchased 18,718 Ordinary Shares of 20 Pence each in the capital of the Company (the "Shares") in the market at a volume-weighted average price of $13.6938 per Share through Mizuho Securities USA LLC (MSUSA). The Shares acquired will, in due course, be cancelled.

Nu Holdings delivered strong Q1 results last week, maintaining rapid customer growth and improving monetization, especially in core markets like Brazil. The fintech added 19M new customers in the last year, reaching 119M total customers by the end of Q1. Deposits in Brazil are surging, and so are the fintechs' overall gross profits.

Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the results of the votes of its Combined Shareholders' Meeting.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO

Mastercard continues to deliver mid-teens growth and strong margins, defying concerns about competition and market saturation. Both Mastercard and Visa are essential long-term holdings, with underestimated dominance and significant growth potential, especially in value-added services. Visa is closing the growth gap with Mastercard, but both trade at reasonable valuations given their superior quality and growth outlook.

Apple is offering additional trade-in discounts for new iPhones in China until June 18, according to its website on Friday.

Kayne Anderson remains attractively valued in a premium BDC sector, but recent earnings and weaker distribution coverage warrant caution. Net investment income has declined, and dividend coverage is now tight, raising the risk of a potential cut if conditions don't improve. Portfolio fundamentals are strong with diversified, first-lien, floating-rate debt, but rising non-accruals and high rates present headwinds.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=149874&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

Regulated Information Nyrstar NV releases notice for the 2024 annual general shareholders' meeting to be held on 24 June 2025 23 May 2025 at 07.00 CEST Nyrstar NV (the “Company”) today issued the notice for the 2024 annual general shareholders' meeting to be held on 24 June 2025 at 11:00 a.m. CEST. The annual general meeting will be held physically with no virtual option available.

MARSEILLE, France--(BUSINESS WIRE)-- #immunotherapy--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the presentation of long-term follow-up data from the Phase 2 TELLOMAK clinical trial evaluating lacutamab, an anti-KIR3DL2 monoclonal antibody, in patients with Sézary syndrome (SS) and mycosis fungoides (MF), two rare and aggressive forms of cutaneous T-cell lymphoma (CTCL). The results will be presented at the American Society of Clinical Oncol.

MARSEILLE, France--(BUSINESS WIRE)-- #AG--Outcome of Innate Pharma's 2025 Annual General Meeting.

Brookfield Infrastructure offers stable, inflation-protected returns from a diverse portfolio of physical assets, making it attractive in today's volatile market environment. BIP's affiliation with Brookfield enhances deal flow and financing, boosting efficiency and shareholder value. Despite seemingly high payout ratios, the Company's cash flows comfortably cover its nearly 6% dividend, which we view as safe and set to grow.

Oil headed for its first weekly decline in three, as OPEC+ members discussed another major production increase. Bloomberg's Nicholas Lua breaks down the situation.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=149873&wire=1&utm_campaign=2 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=149872&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.